Long-Term Assets: The sum of all assets classified as non-current.
BioNTech SE Sponsored ADR (BNTX) had Long-Term Assets of $6.49B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$138.22M |
|
$-622.54M |
|
$83.57M |
|
$54.66M |
|
$931.17M |
|
$-792.95M |
|
$128.04M |
|
$-664.90M |
|
$-664.90M |
|
$-622.54M |
|
$-622.54M |
|
$-622.54M |
|
$-622.54M |
|
$-792.95M |
|
$-650.98M |
|
253.27M |
|
253.27M |
|
$-2.46 |
|
$-2.46 |
|
| Balance Sheet Financials | |
$18.18B |
|
$1.30B |
|
|
Long-Term Assets |
$6.49B |
$24.67B |
|
$2.07B |
|
$288.04M |
|
$715.47M |
|
$2.78B |
|
$21.88B |
|
$19.64B |
|
$21.88B |
|
252.88M |
|
| Cash Flow Statement Financials | |
$-492.74M |
|
$3.10B |
|
$30.90M |
|
$8.98B |
|
$11.63B |
|
$2.65B |
|
$24.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.80 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
39.54% |
|
-573.67% |
|
-573.67% |
|
-- |
|
-481.03% |
|
-450.38% |
|
$-557.34M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.69 |
|
0.20 |
|
459.75 |
|
-2.84% |
|
-3.17% |
|
-2.52% |
|
-2.81% |
|
$86.54 |
|
$-2.20 |
|
$-1.95 |
|